Three highly complementary studies published in this issue of PLoS Medicine address this important question and identify the proapoptotic molecule BIM (BCL2-interacting mediator of cell death, also called BCL2-like 11) as critical mediator of EGFR TKI-induced cell death in EGFR-driven cancer [16–18]. Here, BCL2L11 is linked to cancer.